In selective cases, PD-L1 studies might be helpful, but in the early stages, PD-L1 status does not seem to be associated with prognostic factors, and it may be more valuable to investigate PD-L1 status in advanced-stage BCC and cSCC. The gene discussed is CD274; the disease is skin basal cell carcinoma.